Background Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer and
a leading cause of cancer-related deaths worldwide. The major risk factors for HCC …

Liver fibrosis is a clinically significant finding that has major impacts on patient morbidity and
mortality. The mechanism of fibrosis involves many different cellular pathways, but the major …

Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death.
Although the burden of alcohol-and NASH-related HCC is growing, chronic viral hepatitis …

Hepatitis C virus (HCV) infection is the major risk factor for liver cirrhosis and hepatocellular
carcinoma (HCC). The mechanisms of HCC initiation, growth, and metastasis appear to be …

Conclusions In a large cohort of DAA‐treated patients with cirrhotic HCV, GRS was
associated with de novo HCC independently of classical risk factors, including liver disease …

Direct-acting antivirals (DAAs) induce a rapid virologic response (SVR) in up to 99% of
chronic hepatitis C patients. The role of SVR by DAAs on the incidence or recurrence of …

Background & Aims Little is known about how a sustained virologic response (SVR) to
treatment of hepatitis C virus infection with direct-acting antivirals (DAAs) affects patient …

Background & Aims Hepatitis C virus (HCV) eradication with direct-acting antivirals reduces
hepatocellular carcinoma (HCC) risk. Pooled HCC incidence rates by cirrhosis status and …

Treatment of hepatitis C with direct-acting antivirals is safe and highly efficacious, resulting
in viral clearance (sustained virological response [SVR]) in the vast majority of patients …

The long‐term effects of direct‐acting antiviral therapies (DAAs) for chronic hepatitis C
(CHC) remain uncertain. The objective of this systematic review and meta‐analysis was to …